DSGN
Price
$3.33
Change
-$0.30 (-8.26%)
Updated
May 7 closing price
Capitalization
206.07M
95 days until earnings call
IDYA
Price
$17.83
Change
+$0.08 (+0.45%)
Updated
May 7 closing price
Capitalization
1.55B
96 days until earnings call
Ad is loading...

DSGN vs IDYA

Header iconDSGN vs IDYA Comparison
Open Charts DSGN vs IDYABanner chart's image
Design Therapeutics
Price$3.33
Change-$0.30 (-8.26%)
Volume$82.56K
Capitalization206.07M
IDEAYA Biosciences
Price$17.83
Change+$0.08 (+0.45%)
Volume$1.47M
Capitalization1.55B
DSGN vs IDYA Comparison Chart
Loading...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DSGN vs. IDYA commentary
May 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a Buy and IDYA is a Hold.

Ad is loading...
COMPARISON
Comparison
May 08, 2025
Stock price -- (DSGN: $3.33 vs. IDYA: $17.83)
Brand notoriety: DSGN and IDYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 55% vs. IDYA: 105%
Market capitalization -- DSGN: $206.07M vs. IDYA: $1.55B
DSGN [@Biotechnology] is valued at $206.07M. IDYA’s [@Biotechnology] market capitalization is $1.55B. The market cap for tickers in the [@Biotechnology] industry ranges from $309.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whileIDYA’s FA Score has 0 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • IDYA’s FA Score: 0 green, 5 red.
According to our system of comparison, IDYA is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 3 TA indicator(s) are bullish while IDYA’s TA Score has 3 bullish TA indicator(s).

  • DSGN’s TA Score: 3 bullish, 7 bearish.
  • IDYA’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, both DSGN and IDYA are a bad buy in the short-term.

Price Growth

DSGN (@Biotechnology) experienced а -31.48% price change this week, while IDYA (@Biotechnology) price change was -11.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.50%. For the same industry, the average monthly price growth was +10.18%, and the average quarterly price growth was -13.34%.

Reported Earning Dates

DSGN is expected to report earnings on Aug 11, 2025.

IDYA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-4.50% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.56B) has a higher market cap than DSGN($206M). IDYA YTD gains are higher at: -30.623 vs. DSGN (-46.029). DSGN has higher annual earnings (EBITDA): -61.79M vs. IDYA (-323.14M). IDYA has more cash in the bank: 676M vs. DSGN (245M). DSGN has less debt than IDYA: DSGN (2.33M) vs IDYA (19.2M). IDYA has higher revenues than DSGN: IDYA (7M) vs DSGN (0).
DSGNIDYADSGN / IDYA
Capitalization206M1.56B13%
EBITDA-61.79M-323.14M19%
Gain YTD-46.029-30.623150%
P/E RatioN/AN/A-
Revenue07M-
Total Cash245M676M36%
Total Debt2.33M19.2M12%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
65
SMR RATING
1..100
49
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DSGNIDYA
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
61%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 9 days ago
87%
Bullish Trend 7 days ago
76%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 3 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
73%
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
77%
View a ticker or compare two or three
Ad is loading...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BBVLX16.810.07
+0.42%
Bridge Builder Large Cap Value
DRLAX8.54N/A
N/A
BNY Mellon Developed Markets RE Scs - A
MRRFX16.06N/A
N/A
BlackRock Mid-Cap Value R
FFALX15.84N/A
N/A
Franklin Global Allocation A
SIPIX28.85N/A
N/A
SEI Mid-Cap I (SIMT)

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with KRYS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
-8.26%
KRYS - DSGN
46%
Loosely correlated
-1.91%
VRDN - DSGN
45%
Loosely correlated
+2.16%
COGT - DSGN
43%
Loosely correlated
+0.43%
RCKT - DSGN
42%
Loosely correlated
+6.18%
NTLA - DSGN
41%
Loosely correlated
+0.55%
More